STOCK TITAN

Levi Strauss & Co. SEC Filings

LEVI NYSE

Welcome to our dedicated page for Levi Strauss & Co. SEC filings (Ticker: LEVI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Levi Strauss & Co. filings document formal disclosures for a global apparel issuer, including Form 8-K reports on operating results, officer and director changes, board appointments and amendments to bylaws. Recent filings also record shareholder-vote outcomes and exhibits tied to quarterly and fiscal-year financial releases.

The company's proxy materials cover director elections, executive compensation, board committee matters, annual-meeting procedures and shareholder voting matters. Governance disclosures include advance-notice provisions, universal proxy rule updates, meeting-administration provisions, indemnification matters and equity awards under the company's incentive plan.

Rhea-AI Summary

Levi Strauss & Co. (LEVI) reported an insider transaction by a director. On 11/04/2025, the director acquired 221 dividend equivalent rights (DERs) tied to Class A Common Stock at $0.00, bringing Class A shares beneficially owned to 70,324 (direct).

The filing also shows the acquisition of 42 DERs tied to Class B Common Stock at $0.00. Each Class B share is convertible into one Class A share and has no expiration date. Certain DERs deliver on a deferred basis, and unvested awards (and related DERs) vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of grant. Following the transaction, the director held 57,506 derivative securities (direct).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Levi Strauss & Co. (LEVI) reported an insider transaction on Form 4. A director acquired 106 shares of Class A Common Stock on 11/04/2025 at $0.00 per share, credited as dividend equivalent rights (DERs) tied to existing awards. Following this transaction, the director’s direct holdings total 22,751 shares.

According to the footnote, DERs represent contingent rights that are delivered on the same schedule as the underlying awards, with unvested awards (and related DERs) vesting 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the award’s grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Levi Strauss & Co. (LEVI): A company director reported acquiring 83 shares of Class A Common Stock on 11/04/2025 at a price of $0.00. The shares reflect dividend equivalent rights (DERs), which grant a contingent right to receive one share upon settlement.

After this transaction, the director beneficially owns 11,717 shares, held directly. The DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the underlying award grant; certain underlying awards include deferred delivery, and the same terms apply to the related DERs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Levi Strauss & Co. (LEVI) reported a director acquisition on a Form 4. On 11/04/2025, the director acquired 100 shares of Class A Common Stock at $0.00, arising from dividend equivalent rights (DERs). Following the transaction, the director beneficially owned 14,176 shares directly.

The filing explains that each DER represents a contingent right to receive one share upon settlement and vests and is delivered consistent with the underlying awards. Unvested awards and related DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant; certain fully vested awards have deferred delivery terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Levi Strauss & Co. (LEVI) reported an insider transaction: a company director acquired 142 shares of Class A Common Stock on 11/04/2025 at a price of $0.00 per share. Following the transaction, the director beneficially owns 64,712 shares, held directly.

The shares reflect dividend equivalent rights (DERs), which grant a contingent right to receive one share upon settlement. According to the disclosure, DERs vest and are delivered on the same schedule as their related awards. Unvested awards and related DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Certain underlying awards are fully vested but have deferred delivery; the same terms apply to the related DERs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Levi Strauss & Co. (LEVI) reported insider activity: a director recorded awards on 11/04/2025. The filing shows 85 dividend equivalent rights tied to Class A Common Stock at $0.00, bringing directly held Class A shares to 64,527 after the transaction.

Separately, the report lists 114 derivative rights associated with Class B/Common Stock mechanics at $0.00. Each Class B share is convertible into one Class A share and has no expiration date. The Class B-related DERs are fully vested and subject to a deferral delivery feature.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Levi Strauss & Co. filed a Form 4 showing a director acquired shares via dividend equivalents. On 11/04/2025, the director acquired 111 shares of Class A Common Stock at $0.00, credited as dividend equivalent rights (DERs) tied to prior awards. After this transaction, the director beneficially owns 60,473 shares, held directly.

DERs represent a contingent right to receive one share upon settlement and are delivered on the same schedule as the underlying awards. Unvested awards and related DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date; certain underlying awards are fully vested but subject to deferred delivery, with the same terms applying to related DERs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Levi Strauss & Co. (LEVI) director reported equity activity on Form 4. On 11/04/2025, 358 dividend equivalent rights (DERs) were acquired and settled into Class A common stock at $0.00, bringing direct Class A holdings to 94,173 shares.

The filing also reports 320 DERs tied to Class B common stock at $0.00, with Class B convertible into Class A on a 1:1 basis. Following these transactions, 219,418 derivative securities are held directly. DERs vest and deliver in line with the underlying awards, with certain grants subject to deferred delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Levi Strauss & Co. (LEVI) director reported transactions on 11/04/2025. The insider acquired 85 shares of Class A common stock via dividend equivalent rights (DERs) at $0.00. Following this, the insider beneficially owns 172,701 Class A shares, held directly.

The filing also shows acquisition of 101 Class B DERs, each convertible into one Class A share; derivative holdings total 14,196. Class B shares are convertible to Class A on a 1:1 basis with no expiration. The Class A DERs vest 100% by the earlier of the day before the next annual meeting or the first anniversary of the grant, while the Class B DERs are fully vested and subject to deferred delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Levi Strauss & Co. (LEVI) disclosed a Form 4 for a director reporting equity grants on 11/04/2025. The filing shows the acquisition of 85 shares of Class A Common Stock at $0.00, reported as dividend equivalent rights (DERs). Following this transaction, 122,701 Class A shares were beneficially owned on a direct basis.

The filing also reports 331 derivative securities acquired at $0.00, described as DERs that convey a contingent right to receive one share upon settlement; certain DERs are fully vested with a deferral delivery feature. Each share of Class B Common Stock is convertible into one Class A share at the holder’s option and has no expiration date. Derivative securities beneficially owned following the reported transactions totaled 46,500.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Levi Strauss & Co. (LEVI) SEC filings are available on StockTitan?

StockTitan tracks 159 SEC filings for Levi Strauss & Co. (LEVI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Levi Strauss & Co. (LEVI)?

The most recent SEC filing for Levi Strauss & Co. (LEVI) was filed on November 6, 2025.